
Dicerna Receives Orphan Drug Designation From US Food and Drug Administration for DCR-A1AT for Treatment of Alpha-1 Antitrypsin Deficiency StreetInsider.com
“liver cancer” – Google News

Dicerna Receives Orphan Drug Designation From US Food and Drug Administration for DCR-A1AT for Treatment of Alpha-1 Antitrypsin Deficiency StreetInsider.com
“liver cancer” – Google News